Monitor for any subsequent open-market purchases or sales by Zhou, and for any shareholder communications or proposals that may signal a shift from passive to active involvement. The director appointment and gift suggest insider alignment, but the lack of stated activist intent limits near-term catalyst.
Price Chart
Executive Summary
Ming Zhou filed a Schedule 13D disclosing beneficial ownership of 20,000,000 shares (20.2%) of Goldenwell Biotech, acquired via a gift from CEO Shuang Liu on October 8, 2026. The filing coincides with Zhou's appointment as a director the same day, and she states no present plans for control changes, though she reserves the right to review her position. The gift-based stake and director appointment suggest insider alignment rather than an activist campaign, but the large block creates potential overhang.
Key Financial Metrics
Key Facts
- Ming Zhou acquired 20,000,000 shares (20.2% of outstanding) via a gift from CEO Shuang Liu on October 8, 2026.
- Zhou was appointed as a director of Goldenwell Biotech on the same day.
- The filing states no present plans for mergers, asset sales, board changes, or other extraordinary transactions.
- Zhou reserves the right to increase or decrease her position and may engage with management on business strategy.
- The 8-K filed the same day confirms the gift and director appointment, with no family relationship between Zhou and other officers/directors.
Financial Impact
20.2% stake acquired via gift — no cash consideration; potential overhang from a large concentrated position.
Risk Factors
- Potential overhang if Zhou decides to sell shares, given the 20.2% block.
- Lack of trading liquidity — stock may not be actively traded, making large transactions difficult.
- Uncertainty about Zhou's long-term intentions despite current passive stance.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D Filing (Primary) | 0001477932-26-006150 |
| Document: 0001477932-26-006150-index.html | 0001477932-26-006150 |
| Document: 0001477932-26-006150.txt | 0001477932-26-006150 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | SC 13D | $0.6897 $0.6000 | ▼ −13.01% | ▼ −11.04% | $0.6500 (−5.76%) |
Oct 9, 2026 18d ago | 3 | $0.6897 $0.6000 | ▼ −13.01% | ▼ −11.04% | $0.6500 (−5.76%) |
Oct 9, 2026 18d ago | 8-K | $0.6897 $0.6000 | ▲ +13.01% | ▲ +11.04% | $0.6500 (+5.76%) |
Sep 29, 2026 27d ago | 8-K | $0.6897 $0.6897 | · 0.00% | ▲ +1.95% | $0.6500 (+5.76%) |
Jun 29, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
Jun 26, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
Jun 26, 2026 17w ago | 10-Q/A | $0.5200 $0.5200 | · 0.00% | ▲ +1.39% | $0.6500 (−25.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers